|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2006
Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1
1 Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 2 Dept of Thoracic Medicine, Institute of Medicine, and 3 Section for Medical Genetics and Molecular Medicine, Dept of Clinical Medicine, University of Bergen, Bergen, Norway.
CORRESPONDENCE: J. Brøgger, Dept of Neurology, Haukeland University Hospital, Helse Bergen HF, Jonas Liesv. 65, Bergen N-5021, Norway. E-mail: jan.brogger{at}med.uib.no
Keywords: ß2-adrenergic receptor, case–control study, chronic obstructive pulmonary disease, genetics, microsomal epoxide hydroxylase, tumour necrosis factor-
Received: May 15, 2005
Accepted December 9, 2005
There is evidence of a hereditary component in chronic obstructive pulmonary disease (COPD). A number of genetic association studies have been performed to find susceptibility genes of COPD.
The current authors performed a case–control, genetic-association study and a meta-analysis of 16 studies, involving seven polymorphisms in three well-studied genes: microsomal epoxide hydroxylase (EPHX1); tumour necrosis factor; and ß2-adrenoreceptor. A total of 492 Caucasian smokers and former smokers were recruited from hospital databases and population cohort studies.
In the present study, a protective effect of the EPHX1 Tyr113His polymorphism was found (homozygous odds ratio (OR) 0.5). In the meta-analysis, homozygotes for this single nucleotide polymorphism (SNP) also had a pooled OR of 0.5. The same effect has been found in several lung cancer studies. Effects for other candidate SNPs were weak or statistically insignificant, and probable genotyping error was common.
In conclusion, the present data and meta-analysis support a role for microsomal epoxide hydroxylase in the aetiology of chronic obstructive pulmonary disease.
This article has been cited by other articles:
|
|
 |
|
  J. Smolonska, C. Wijmenga, D. S. Postma, and H. M. Boezen Meta-analyses on Suspected Chronic Obstructive Pulmonary Disease Genes: A Summary of 20 Years' Research Am. J. Respir. Crit. Care Med., October 1, 2009; 180(7): 618 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yang, S.-H. Liang, D. M. Weyant, P. Lazarus, C. J. Gallagher, and C. J. Omiecinski The Expression of Human Microsomal Epoxide Hydrolase Is Predominantly Driven by a Genetically Polymorphic Far Upstream Promoter J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 23 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S J Marciniak and D A Lomas What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax, April 1, 2009; 64(4): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Castaldi, C. P. Hersh, J. J. Reilly, and E. K. Silverman Genetic Associations With Hypoxemia and Pulmonary Arterial Pressure in COPD Chest, March 1, 2009; 135(3): 737 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Siedlinski, D. S. Postma, H. A. Smit, and H. M. Boezen No effects of EPHX1 polymorphisms on the level or change of FEV1 in the general population Eur. Respir. J., February 1, 2009; 33(2): 446 - 449. [Full Text] [PDF]
|
|
|
|
|
|
S. Chappell, L. Daly, K. Morgan, T. Guetta-Baranes, J. Roca, R. Rabinovich, J. Lotya, A. B. Millar, S. C. Donnelly, V. Keatings, et al. Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD Eur. Respir. J., October 1, 2008; 32(4): 931 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ammous, N. R. Hackett, M. W. Butler, T. Raman, I. Dolgalev, T. P. O'Connor, B.-G. Harvey, and R. G. Crystal Variability in Small Airway Epithelial Gene Expression Among Normal Smokers Chest, June 1, 2008; 133(6): 1344 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Hersh, D. L. DeMeo, and E. K. Silverman National Emphysema Treatment Trial State of the Art: Genetics of Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Gingo, L. J. Silveira, Y. E. Miller, A. L. Friedlander, G. P. Cosgrove, E. D. Chan, L. A. Maier, and R. P. Bowler Tumour necrosis factor gene polymorphisms are associated with COPD Eur. Respir. J., May 1, 2008; 31(5): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri Update in Chronic Obstructive Pulmonary Disease 2006 Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Boezen and D. S. Postma Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Eur. Respir. J., January 1, 2007; 29(1): 8 - 10. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |